Previous 10 | Next 10 |
BioNTech SE (NASDAQ: BNTX ) -16% . More news on: BioNTech SE, Mesoblast Limited, InterContinental Hotels Group PLC, Stocks on the move, , Read more ...
Sasol (NYSE: SSL ) -36% . More news on: Sasol Limited, Sibanye Stillwater Limited, Caesars Entertainment Corporation, Stocks on the move, , Read more ...
Quorum Health (NYSE: QHC ) -53% . More news on: Quorum Health Corporation, Sasol Limited, Enable Midstream Partners, LP, Stocks on the move, Read more ...
It is an exciting time in biotech. It seems like the big challenges are within reach. Cancer, diabetes, infectious diseases. Not everything, not right away. There are still a lot of bald men, for example. And unfortunately, Alzheimer’s seems intractable. But for investors that can mea...
Big Lots (NYSE: BIG ) -35% on Q4 earnings . More news on: Big Lots, Inc., Tonix Pharmaceuticals Holding Corp., Celsion Corporation, Stocks on the move, , Read more ...
Anaplan (NYSE: PLAN ) -29% despite Q4 beat . More news on: Anaplan, Inc., Continental Resources, Inc., Nutanix, Inc., Stocks on the move, , Read more ...
The biotech sector has been one of the better stock market performers for some time now, and the trend continued in 2020 as well so far. One of the biotech stocks that deserve attention at this point is that of Genprex Inc ( NASDAQ: GNPX ) , which has emerged as the biggest biotech stock gai...
Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX ), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced today that it closed its previously announc...
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, on Wednesday announced that it has entered into securities purchase agreements with institutional investors for the purchase and ...
Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Genprex Issues Stockholder Letter and Provides 2024 Corporate Update PR Newswire Company Achieves Multiple Clinical Development Milestones in 2024 Patient Treatment Continues in Three Lung Cancer Clinical Trials AUSTIN, Texas , June 27, 2024 /PRNe...
Genprex to Present at the 2024 BIO International Convention PR Newswire Presentation to Highlight the Company's Gene Therapies for Cancer and Diabetes AUSTIN, Texas , May 30, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: ...